Trevi Therapeutics, Inc. TRVI Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount
Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount at other companies
Other financials
Where this comes from
Reported directly by Trevi Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxReconciliationTaxCreditsResearch.
The official record: Trevi Therapeutics, Inc.’s 10-K, filed March 17, 2026, on SEC EDGAR. View the filing →
Ask your AI about Trevi Therapeutics, Inc.'s effective income tax rate reconciliation, tax credit, research, amount.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Trevi Therapeutics, Inc.'s effective income tax rate reconciliation, tax credit, research, amount?
- Trevi Therapeutics, Inc. (TRVI) reported effective income tax rate reconciliation, tax credit, research, amount of $295.25K in Q4 2025.
- How has Trevi Therapeutics, Inc.'s effective income tax rate reconciliation, tax credit, research, amount changed year-over-year?
- Trevi Therapeutics, Inc.'s effective income tax rate reconciliation, tax credit, research, amount increased by 5.8% year-over-year, from $279K to $295.25K.
- What is the long-term trend for Trevi Therapeutics, Inc.'s effective income tax rate reconciliation, tax credit, research, amount?
- Over 2 years (2022 to 2025), Trevi Therapeutics, Inc.'s effective income tax rate reconciliation, tax credit, research, amount has grown at a -53.2% compound annual growth rate (CAGR), from $5.4M to $1.18M.
- What does effective income tax rate reconciliation, tax credit, research, amount mean?
- Represents the monetary value of research and development tax credits applied to reduce the company's income tax expense. These credits are typically granted by governments to incentivize innovation and clinical development activities. This metric is particularly significant for clinical-stage companies as it highlights the utilization of tax incentives to offset operational costs.